Drug-induced tolerant persisters in tumor: mechanism, vulnerability and perspective implication for clinical treatment
Abstract Cancer remains a significant global health burden due to its high morbidity and mortality. Oncogene-targeted therapy and immunotherapy have markedly improved the 5-year survival rate in the patients with advanced or metastatic tumors compared to outcomes in the era of chemotherapy/radiation...
Saved in:
| Main Authors: | Shujie Liu, Anfeng Jiang, Faqing Tang, Minghao Duan, Bin Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02323-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Immunology at the feto-maternal interface
by: Amir-Hassan Zarnani, et al.
Published: (2025-08-01) -
Drug-tolerant persister cell in cancer: reversibility, microenvironmental interplay, and therapeutic strategies
by: Haifeng Li, et al.
Published: (2025-08-01) -
Heavy metals promote the formation of multidrug-tolerant Staphylococcus aureus and Escherichia coli persisters
by: Seongeun Baek, et al.
Published: (2025-03-01) -
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
by: Zhe Zhang, et al.
Published: (2022-01-01) -
Persistent trophoblastic tumors
by: M. N. Tikhonovskaya, et al.
Published: (2014-07-01)